Skip to content

Based on "phlegm-stasis and collateralization", explore the efficacy of GLXBBX Decoction in the treatment of COPD related PH and the study of intestinal bacteria-metabolism

Based on "phlegm-stasis and collateralization", explore the efficacy of GLXBBX Decoction in the treatment of COPD related PH and the study of intestinal bacteria-metabolism

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073548
Enrollment
Unknown
Registered
2023-07-14
Start date
2022-01-01
Completion date
Unknown
Last updated
2023-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD associated pulmonary hypertension

Interventions

Observation group:Conventional Western medicine + flavoured Fructus Sanalou Stemon white Pinellia Soup
Control group:Conventional western medicine treatment
Health Section:N/A

Sponsors

Zigong First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: ? Patients diagnosed with PH caused by AECOPD; (2) In accordance with the TCM syndrome differentiation and classification standards of the TCM Diagnosis and Treatment Guide for Chronic Obstructive Pulmonary Disease (2011 edition) formulated by the Pulmonary Diseases Specialty Committee of the Internal Medicine Branch of the Chinese Association of Traditional Chinese Medicine; ? Age 40-80 years old, male and female; ? Subjects agree to participate in the experiment and sign the informed consent voluntarily.

Exclusion criteria

Exclusion criteria: ? Patients diagnosed with PH caused by AECOPD; ? Consistent with the above TCM syndrome differentiation types; ? Age 40-80 years old, male and female; ? Subjects agree to participate in the experiment and sign the informed consent voluntarily.

Design outcomes

Primary

MeasureTime frame
pulmonary arterial hypertension;Cardiac function grading changes;TCM syndrome score;

Secondary

MeasureTime frame
FEV1/FVC?FEV1?FVC;6MWD;mMRC and SGRQ scores;CAT Questionnaire Scale;BNP;D- dimer;FIB;Blood gas analysis;

Countries

China

Contacts

Public ContactLiuying Li

Zigong First People's Hospital

243956438@qq.com+86 158 0823 0266

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026